Литература
1. Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation. 2011; 124(20):2264-2274.
2. Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG et al. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. Arch Intern Med. 2005; 165(10): 1185-1191.
3. Freeman JV, Wang Y, Akar J, Desai N, Krumholz H. National Trends in Atrial Fibrillation Hospitalization, Readmission, and Mortality for Medicare Beneficiaries, 1999-2013. Circulation 2017; 135(13): 1227-1239. doi: 10.1161/CIRCULATIONAHA.116.022388.
4. Lip GY, Heinzel FR, Gaita F, Juanatey JR, Le Heuzey JY, Potpara T et al. European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Eur J Heart Fail. 2015; 17(9): 848-74. doi: 10.1002/ejhf.338.
5. Katritsis DG, Boriani G, Cosio FG, Jais P, Hindricks G, Josephson ME et al. Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). Arrhythm Electrophysiol Rev. 2016; 5(3):210-224. doi: 10.15420/aer.2016:5.3.GL1.
6. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129-2200. doi: 10.1093/eurheartj/ehw128.
7. Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Беграмбекова Ю.Л., Васюк Ю.А., Гарганеева А.А и др. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология. 2018;58(6S):8-158. doi: 10.18087/cardio.2475
8. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003; 107(23): 2920-2925.
9. Heist EK, Ruskin JN. Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment. Prog Cardiovasc Dis. 2006; 48(4): 256-269.
10. Haissaguerre M, Wright M, Hocini M, Jais P. The substrate maintaining persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2008; 1(1): 2-5. doi: 10.1161/CIRCEP.108.764233.
11. Kurita T, Motoki K, Yasuoka R, Hirota T, Akaiwa Y, Kotake Y et al. Rhythm control should be better for the management of patients with atrial fibrillation and heart failure--rhythm control vs. rate control: which is better in the management of atrial fibrillation? (Rhythm-side). Circ J. 2011; 75(4):979-85.
12. Tayebjee MH, Hunter RJ, Baker V, Creta A, Duncan E, Sporton S et al. Pulmonary vein isolation with radiofrequency ablation followed by cryotherapy: a novel strategy to improve clinical outcomes following catheter ablation of paroxysmal atrial fibrillation. Europace. 2011; 13(9): 1250-1255. doi: 10.1093/europace/eur140.
13. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38):2893-2962.
14. Сулимов В.А., Голицын С.П., Панченко Е.П. Диагностика и лечение фибрилляции предсердий. Российский кардиологический журнал. 2013;(4s3) 5-100. doi: 10.15829/1560-4071-2013-4s3-5-100.
15. Du H, Wonggom P, Tongpeth J, Clark RA. Six-Minute Walk Test for Assessing Physical Functional Capacity in Chronic Heart Failure. Curr Heart Fail Rep. 2017; 14(3):158-166. doi: 10.1007/s11897-017-0330-3.
16. Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE open medicine. 2016; 4: 2050312116671725. doi: 10.1177/2050312116671725
17. Margulescu AD, Mont L. Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management. Expert Rev Cardiovasc Ther. 2017; 15(8): 601-618. doi: 10.1080/14779072.2017.1355237.
18. Котанова Е.С., Рзаев Ф.Г., Сичинава Н.В., Дишеков М.Р., Барсамян С.Ж., Гоголадзе Д.К. Отдаленные результаты изолированной электрической изоляции устьев легочных вен методом радиочастотной аблации у больных с пароксизмальной и персистентной формами фибрилляции предсердий. Анналы аритмологии. 2009: 78-86.
19. De Potter T, Hunter TD, Boo LM, Chatzikyriakou S, Strisciuglio T, Silva E et al. The industrialization of ablation: a highly standardized and reproducible workflow for radiofrequency ablation of atrial fibrillation. J Interv Card Electrophysiol. 2019. doi: 10.1007/s10840-019-00622-y.
20. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018; 379(5): 492. doi: 10.1056/NEJMoa1707855.